There also may not be enough information yet for groups that scientists are just now beginning to study in clinical trials like adolescents with type 2 diabetes or obesity, though the FDA has already approved several GLP-1 agonists for these groups (14,15)
Together, these peptides became of interest for laboratory research into growth hormone regulation, recovery, and metabolic processes
These peptides can target specific areas, supporting tissue repair, hormone regulation, and immune function
Healthcare providers may recommend GLP-1 medications for those struggling with long-term weight management when other methods are ineffective
10.1155/2022/7520632 3 AyalaA.MuozM
Pharmacological effects and clinical applications of propionyl-L-carnitine